VERVESymposium 2021: The Xeltis Hemodialysis Access Graft | Prof Frans Moll

Подробнее о видео

Watch the full video on Radcliffe Vascular here:

In this video interview from VERVE 2021, Professor Frans Moll (University Medical Center Utrecht, Utrecht, NL) discusses the Xeltis Hemodialysis Access Graft, a new generation AV graft utilising endogenous tissue restoration. Prof Moll outlines the pre-clinical and clinical evidence supporting the use of this stent and discusses the first in human aXess study.

Discussion Points:
1. The Xeltis Hemodialysis Access Graft
2. Previous Research
3. Study Design and Patient Population
4. Next Steps

Recorded Remotely from Utrecht, 2021.

Interviewer: Jordan Rance
This content is intended for healthcare professionals only.

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.